Exchange Traded Concepts’s Rhythm Pharmaceuticals RYTM Stock Holding History

Exchange Traded Concepts’s Portfolio RYTM Stock Details RYTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$736K	Buy	8,463 +2,383	+39%	+$232K	0.01%	934
2025 Q4	$651K	Sell	6,080 -306	-5%	-$32.5K	0.01%	957
2025 Q3	$645K	Buy	+6,386	New	+$593K	0.01%	962
2025 Q2	–	Sell	-11,912	Closed	-$631K	–	1490
2025 Q1	$631K	Sell	11,912 -463	-4%	-$25.7K	0.01%	751
2024 Q4	$693K	Sell	12,375 -2,682	-18%	-$148K	0.01%	726
2024 Q3	$789K	Buy	15,057 +3,137	+26%	+$150K	0.02%	616
2024 Q2	$489K	Buy	+11,920	New	+$476K	0.01%	707

Other funds holding RYTM

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Exchange Traded Concepts's RYTM Position: Q1 2026 in Review

Exchange Traded Concepts increased its Rhythm Pharmaceuticals (RYTM) stake by 39% in Q1 2026, buying an estimated $232K and bringing the position to 8,463 shares worth $736K. The position accounts for 0.01% of the portfolio, ranked #934.

Exchange Traded Concepts first reported a position in RYTM in Q2 2024 and has held it in 7 quarters since. The position peaked at $789K in Q3 2024. 285 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.

Exchange Traded Concepts held 8,463 shares of Rhythm Pharmaceuticals worth $736K as of Q1 2026.
Exchange Traded Concepts bought 2,383 Rhythm Pharmaceuticals shares in Q1 2026, an estimated $232K.
Rhythm Pharmaceuticals made up 0.01% of Exchange Traded Concepts's portfolio in Q1 2026, its #934 holding.
Exchange Traded Concepts first reported a position in Rhythm Pharmaceuticals in Q2 2024 and has held it in 7 quarters since.
Exchange Traded Concepts's Rhythm Pharmaceuticals position peaked at $789K in Q3 2024.
285 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.

Based on Exchange Traded Concepts's 13F filing for Q1 2026, filed 15 Apr 2026.